NEW YORK, April 21 (GenomeWeb News) - Serologicals said today that its Chemicon International subsidiary has signed an agreement with the AustralianStemCellCenter that will allow Chemicon exclusive rights to commercialize, market, and distribute stem cell reagents developed by ASCC worldwide.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

CNN reports that researchers have tied a new variant to opioid addiction risk.

Organoids derived from patients' tumors may help determine what chemotherapy treatment patients would benefit from, according to New Scientist.

An initiative from GenomeAsia 100K hopes to increase the number of South Asians in genetic research, according to NBC News.

In Science this week: genomic analysis of ancient and modern horses indicates population turnover, and more.